Gritstone Bio, Inc.
CAGE Code: 9L4G1
NCAGE Code: 9L4G1
Status: Active
Type: Commercial Supplier
Summary
Gritstone Bio, Inc. is an Active Commercial Supplier with the Cage Code 9L4G1.
Address
5959 Horton Street
Suite 300
Emeryville CA 94608-2120
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
American Conference Of Governmental Industrial Ladder Co A Div Of Very Good Technology Inc. J B Photographic Services Wondarl Inc Dba Electronic Parts National Cargo Bureau Inc Vituity-California Observation Prolific Machines, Inc Cambria Environmental Technology Inc Vituity-Wisconsin Llc Vituity-Wisconsin Hm S.C. Vituity-Illinois Infectious Disease Vividata, Inc Bcsp Hollis Property Llc Short Thomas A Co Aldon Computer Group U S Flexible Metallic Tubing Co Childrens Book Press Vituity-Wisconsin Em S.C. Sybase Financial Services Inc
Frequently Asked Questions (FAQ) for CAGE 9L4G1
- What is CAGE Code 9L4G1?
- 9L4G1 is the unique identifier used by NATO Organizations to reference the physical entity known as Gritstone Bio, Inc. located at 5959 Horton Street, Suite 300, Emeryville CA 94608-2120, United States.
- Who is CAGE Code 9L4G1?
- 9L4G1 refers to Gritstone Bio, Inc. located at 5959 Horton Street, Suite 300, Emeryville CA 94608-2120, United States.
- Where is CAGE Code 9L4G1 Located?
- CAGE Code 9L4G1 is located in Emeryville, CA, USA.
Contracting History for CAGE 9L4G1 Most Recent 25 Records
- 75A50123C00062
- Developing A Next-Generation Vaccine That Drives (A) More Durable And Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants Of Concern (Vocs), Including Those Not Included In The Vaccine, And (B) T Cells Reactive Against Conserved Targets
- 10 Nov 2023
- Developing A Next-Generation Vaccine That Drives (A) More Durable And Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants Of Concern (Vocs), Including Those Not Included In The Vaccine, And (B) T Cells Reactive Against Conserved Targets
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $9,856,008.00
- Department Of Health And Human Services (Hhs)
- 75A50123C00062
- Developing A Next-Generation Vaccine That Drives (A) More Durable And Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants Of Concern (Vocs), Including Those Not Included In The Vaccine, And (B) T Cells Reactive Against Conserved Targets
- 25 Sep 2023
- Developing A Next-Generation Vaccine That Drives (A) More Durable And Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants Of Concern (Vocs), Including Those Not Included In The Vaccine, And (B) T Cells Reactive Against Conserved Targets
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $9,856,008.00
- Department Of Health And Human Services (Hhs)